ARTICLE

Synthesis and Cytotoxicity of N12-Ethyl Substituted Indolocarbazole Derivatives

  • Ma Hongguang ,
  • Wang Liping ,
  • Xu Zhihong ,
  • Zhang Yapeng ,
  • Li Xia ,
  • Zhu Weiming
Expand
  • a Key Laboratory of Marine Drugs, Ministry Education of China, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003;
    b Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550002;
    c School of Ocean, Shandong University, Weihai 264209

Received date: 2016-02-29

  Revised date: 2016-04-17

  Online published: 2016-05-03

Supported by

Project supported by the National Natural Science Foundation of China (Nos. 81561148012, 41376148, 81273532, 30973680), the National High-Tech R&D Program of China (No. 2012AA092104), and the National Natural Science Foundation of China-Guangdong Fund Joint Project (No. U1406402).

Abstract

Nine new N12-ethyl substituted indolocarbazole derivatives were synthesized. Their structures were identified by 1H NMR, 13C NMR and HRESIMS. The thiazolyl blue tetrazolium bromide (MTT) method was used to evaluate the cytotoxicities of these derivatives against A549, HepG-2 and Hela cell lines, while the cell counting kit-8 (CCK-8) method was used to evaluate cytotoxicity against K562 cell lines. The results showed that compounds 79 displayed comparable cytotoxicity to adriamycin (ADM) against K562 cell lines with the IC50 values of 0.43~0.93 μmol/L. Compounds 8 and 12 showed comparable cytotoxicity to ADM against Hela cell lines with the IC50 values of 1.23 and 0.43 μmol/L, respectively. The hydrochloride 14 of compound 13 exhibited good cytotoxicity against the four cell lines with the IC50 values of 0.23~1.72 μmol/L, indicating a worth of further study as an antitumor lead compound.

Cite this article

Ma Hongguang , Wang Liping , Xu Zhihong , Zhang Yapeng , Li Xia , Zhu Weiming . Synthesis and Cytotoxicity of N12-Ethyl Substituted Indolocarbazole Derivatives[J]. Chinese Journal of Organic Chemistry, 2016 , 36(8) : 1839 -1846 . DOI: 10.6023/cjoc201602035

References

[1] Zhao, C.; Zhu, T.; Zhu, W. Chin. J. Org. Chem. 2013, 33, 1195 (in Chinese).
(赵成英, 朱统汉, 朱伟明, 有机化学, 2013, 33, 1195.)
[2] Ma, H.; Liu, Q.; Zhu, G.; Liu, H.; Zhu, W. J. Asian Nat. Prod. Res. 2016, 18, 92.
[3] Zhao, C.; Liu, H.; Zhu, W. Acta Microbiol. Sin. 2016, 56, 331 (in Chinese).
(赵成英, 刘海珊, 朱伟明, 微生物学报, 2016, 56, 331.)
[4] Zhu, T. H.; Ma, Y. N.; Wang, W. L.; Chen, Z. B.; Qin, S. D.; Du, Y. Q.; Wang, D. Y.; Zhu, W. M. Chin. J. Mar. Drugs 2015, 34, 56 (in Chinese).
(朱统汉, 马颖娜, 王文玲, 陈正波, 秦世冬, 杜玉琪, 王冬阳, 朱伟明, 中国海洋药物, 2015, 34, 56.)
[5] Omura, S.; Iwai, Y.; Hirano, A.; Nakagawa, A.; Awaya, J.; Tsuchiya, H.; Takahashi, Y.; Masuma, R. J. Antibiot. 1977, 30, 275.
[6] Wang, L.; Zhuang, Y.; Sun, K.; Zhu, W. Chin. J. Org. Chem. 2014, 34, 1603 (in Chinese).
(王立平, 庄以彬, 孙坤来, 朱伟明, 有机化学, 2014, 34, 1603.)
[7] Wang, L.; Mei, X.; Wang, C.; Zhu, W. Tetrahedron 2015, 71, 7990.
[8] Gani, O. A.; Engh, R. A. Nat. Prod. Rep. 2010, 27, 489.
[9] Sánchez, C.; Méndez, C.; Salas, J. A. Nat. Prod. Rep. 2006, 23, 1007.
[10] Fu, P.; Zhuang, Y.; Wang, Y.; Liu, P.; Qi, X.; Gu, K.; Zhang, D.; Zhu, W. Org. Lett. 2012, 14, 6194.
[11] Fu, P.; Yang, C.; Wang, Y.; Liu, P.; Ma, Y.; Xu, L.; Su, M.; Hong, K.; Zhu, W. Org. Lett. 2012, 14, 2422.
[12] Pereira, E. R.; Belin, L.; Sancelme, M.; Prudhomme, M.; Ollier, M.; Rapp, M.; Severe, D.; Riou, J. F.; Fabbro, D.; Meyer, T. J. Med. Chem. 1996, 39, 4471.
[13] Labourier, E.; Riou, J. F.; Prudhomme, M.; Carrasco, C.; Bailly, C.; Tazi, J. Cancer Res. 1999, 59, 52.
[14] Zhu, G. X.; Conner, S. E.; Zhou, X.; Chan, H. K.; Shih, C.; Engler, T. A.; Al-Awar, R. S.; Brooks, H. B.; Watkins, S. A.; Spencer, C. D.; Schultz, R. M.; Dempsey, J. A.; Considine, E. L.; Patel, B. R.; Ogg, C. A.; Vasudevan, V.; Lytle, M. L. Bioorg. Med. Chem. Lett. 2004, 14, 3057.
[15] Zhang, H. C.; White, K. B.; Ye, H.; McComsey, D. F.; Derian, C. K.; Addo, M. F.; Andrade-Gordon, P.; Eckardt, A. J.; Conway, B. R.; Westover, L.; Xu, J. Z.; Look, R.; Demarest, K. T.; Emanuel, S.; Maryanoff, B. E. Bioorg. Med. Chem. Lett. 2003, 13, 3049.
[16] Rodriguez-Ariza, A.; Lopez-Pedrera, C.; Aranda, E.; Barbarroja, N. Crit. Rev. Oncol. Hematol. 2011, 80, 241.
[17] Hudkins, R. L.; Becknell, N. C.; Zulli, A. L.; Underiner, T. L.; Angeles, T. S.; Aimone, L. D.; Albom, M. S.; Chang, H.; Miknyoczki, S. J.; Hunter, K.; Jones-Bolin, S.; Zhao, H.; Bacon, E. R.; Mallamo, J. P.; Ator, M. A.; Ruggeri, B. A. J. Med. Chem. 2012, 55, 903.
[18] Ruegg, U. T.; Burgess, G. M. Trends Pharmacol. Sci. 1989, 10, 218.
[19] Bharate, S. B.; Sawant, S. D.; Singh, P. P.; Vishwakarma, R. A. Chem. Rev. 2013, 113, 6761.
[20] Anastassiadis, T.; Deacon, S. W.; Devarajan, K.; Ma, H.; Peterson, J. R. Nat. Biotechnol. 2011, 29, 1039.
[21] Huang, Y. C.; Chao, D. K.; Chao, K. S. C.; Chen, Y. J. Toxicol. In Vitro 2009, 23, 979.
[22] Del Corral, A.; Dutreix, C.; Huntsman-Labed, A.; Lorenzo, S.; Morganroth, J.; Harrell, R.; Wang, Y. Cancer Chemother. Pharmacol. 2012, 69, 1255.
[23] Fischer, T.; Stone, R. M.; Deangelo, D. J.; Galinsky, I.; Estey, E.; Lanza, C.; Fox, E.; Ehninger, G.; Feldman, E. J.; Schiller, G. J.; Klimek, V. M.; Nimer, S. D.; Gilliland, D. G.; Dutreix, C.; Huntsman-Labed, A.; Virkus, J.; Giles, F. J. J. Clin. Oncol. 2010, 28, 4339.
[24] Graul, A. I. Drug News Perspect. 2007, 20, 45.
[25] Levis, M.; Allebach, J.; Tse, K. F., Zheng, R.; Baldwin, B. R.; Smith, B. D.; Jones-Bolin, S.; Ruggeri, B.; Dionne, C.; Small, D. Blood 2002, 99, 3885.
[26] Diaz, T.; Navarro, A.; Ferrer, G.; Gel, B.; Gaya, A.; Artells, R.; Bellosillo, B.; Garcia-Garcia, M.; Serrano, S.; Martínez, A.; Monzo, M. PLoS One 2011, 6, e18856.
[27] Marshall, J. L.; Kindler, H.; Deeken, J.; Bhargava, P.; Vogelzang, N. J.; Rizvi, N.; Luhtala, T.; Boylan, S.; Dordal, M.; Robertson, P.; Hawkins, M. J.; Ratain, M. J. Invest New Drugs 2005, 23, 31.
[28] Knapper, S.; Burnett, A. K.; Littlewood, T.; Kell, W. J.; Agrawal, S.; Chopra, R.; Clark, R.; Levis, M. J.; Small, D. Blood 2006, 108, 3262.
[29] Mackay, H. J.; Twelves, C. J. Nat. Rev. Cancer 2007, 7, 554.
[30] Lee, K. W.; Kim, S. G.; Kim, H. P.; Kwon, E.; You, J.; Choi, H. J.; Park, J. H.; Kang, B. C.; Im, S. A.; Kim, T. Y.; Kim, W. H.; Bang, Y. J. Cancer Res. 2008, 68, 1916.
[31] Padda, S. K.; Krupitskaya, Y.; Chhatwani, L.; Fisher, G. A.; Colevas, A. D.; Pedro-Salcedo, M. S.; Decker, R.; Latz, J. E.; Wakelee, H. A. Cancer Chemother. Pharmacol. 2012, 69, 1013.
[32] Slater, M. J.; Baxter, R.; Bonser, R. W.; Cockerill, S.; Gohil, K.; Parry, N.; Robinson, E.; Randall, R.; Yeates, C.; Snowden, W.; Walters, A. Bioorg. Med. Chem. Lett. 2001, 11, 1993.
[33] Sanchez-Martinez, C.; Shih, C.; Zhu, G. X.; Li, T. C.; Brooks, H. B.; Patel, B. K.; Schultz, R. M.; DeHahn, T. B.; Spencer, C. D.; Watkins, S. A.; Ogg, C. A.; Considine, E.; Dempsey, J. A.; Zhang, F. M. Bioorg. Med. Chem. Lett. 2003, 13, 3841.
[34] Zhang, M.; Sheng, C. Q.; Xu, H.; Song, Y. L.; Zhang, W. N. Sci. China, Ser B: Chem. 2007, 37, 288 (in Chinese).
(张珉, 盛春泉, 徐辉, 宋云龙, 张万年, 中国科学(B辑): 化学, 2007, 37, 288.)
[35] Davis, P. D.; Bit, R. A.; Hurst, S. A. Tetrahedron Lett. 1990, 31, 2353.
[36] Haddach, A. A.; Kelleman, A.; Deaton-Rewolinski, M. V. Tetrahedron Lett. 2002, 43, 399.
[37] Joyce, R. P.; Gainor, J. A.; Weinreb, S. M. J. Org. Chem. 1987, 52, 1177.
[38] Julia, M.; Tchernoff, G. Bull. Soc. Chim. Fr. 1960, 741.
[39] Bocchi, V.; Casnati, G.; Dossena, A.; Villani, F. Synthesis 1976, 414.
Lakatosh, S. A.; Balzarini, J.; Andrei, G.; Snoeck, R.; Lakatosh, A.; De Clercq, E.; Preobrazhenskaya, M. N. J. Antibiot. 2002, 55, 768.

Outlines

/